(-0.16%) 5 460.55 points
(-0.36%) 38 971 points
(0.20%) 17 753 points
(0.45%) $81.19
(-3.48%) $2.66
(-0.92%) $2 309.30
(-0.34%) $28.77
(1.53%) $1 001.50
(0.25%) $0.935
(0.84%) $10.69
(0.35%) $0.791
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas...
Stats | |
---|---|
本日の出来高 | 4 266 |
平均出来高 | 0 |
時価総額 | 626.88M |
EPS | $-0.290 ( Q1 | 2024-05-13 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.510 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0360 (2.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-08 | Scheessele William John | Buy | 276 000 | Stock Options (right to buy) |
2023-12-08 | Prichard Heather Ledbetter | Buy | 290 000 | Stock Options (right to buy) |
2023-12-11 | Prichard Heather Ledbetter | Buy | 525 | Stock Options (right to buy) |
2023-12-08 | Parikh Shamik J | Buy | 283 000 | Stock Options (right to buy) |
2023-12-08 | Cao Yang | Buy | 210 000 | Stock Options (right to buy) |
INSIDER POWER |
---|
-73.68 |
Last 96 transactions |
Buy: 5 191 317 | Sell: 41 628 241 |
Humacyte, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Humacyte, Inc. 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-7.72M (0.00 %) |
EPS: | $-1.070 |
FY | 2023 |
収益: | $0 |
総利益: | $-7.72M (0.00 %) |
EPS: | $-1.070 |
FY | 2022 |
収益: | $1.57M |
総利益: | $-6.69M (-427.48 %) |
EPS: | $0.620 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-0.000660 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Humacyte, Inc.
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。